ARTICLE | Clinical News
Exforge HCT regulatory update
May 11, 2009 7:00 AM UTC
FDA approved an NDA from Novartis for Exforge HCT amlodipine/valsartan/hydrochlorothiazide to treat hypertension. Exforge HCT is an oral fixed-dose combination of the calcium channel blocker amlodipi...